A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)

A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)
复制标题

DOI:
10.1093/jjco/hyl128
复制
发表时间:
2007-01-01
影响因子:
2.4
通讯作者:
Nakagawa, Keiichi
Nakagawa, Keiichi
中科院分区:
医学4区
文献类型:
--
作者:
Nakamura, Naoki;Igaki, Hiroshi;Nakagawa, Keiichi

文献摘要

被引文献

相似文献

目的:评价放射治疗对肝细胞癌(HCC)脊柱骨转移的治疗效果。方法:回顾性分析1995年至2004年接受放射治疗的24例门诊HCC脊柱骨转移患者,分析放疗后的门诊率和局部无进展率。 24 名患者中有 8 名 (33%) 在治疗前因放射影像学检查显示脊髓受压于脊柱骨转移。 24 名患者中有 2 名 (8.3%) 在治疗前有一定的脊柱缺陷。 α/β比值为10时的生物等效剂量(BED)范围为39至50.7 Gy(中位44.8 Gy)。结果:中位观察期为5.1个月,范围为0.9至36.0个月。在 24 名患者中,5 名(21%)接受了挽救治疗,而其余 19 名患者中,4 名(21%)在最后一次随访时变得无法行走。 3 个月和 6 个月时的卧床率分别为 85% 和 63%。 3个月和6个月时的局部无进展率分别为53%和47%。结论:BED为39-50.7 Gy(中位44.8 Gy)的放射治疗对于HCC脊柱骨转移患者预防瘫痪的效果不够。需要评估采用高精度辐射技术的剂量递增。
Objective: To evaluate the therapeutic effects of radiotherapy on spinal bone metastases from hepatocellular carcinoma (HCC).Methods: A retrospective review was conducted on 24 ambulatory patients with spinal bone metastases from HCC treated by radiotherapy from 1995 to 2004. Ambulatory rate and local progression-free rate after radiotherapy were analyzed. Eight (33%) of 24 patients had radiographic spinal cord compression from the spinal bone metastases before the treatment. Two (8.3%) of the 24 patients had some spinal deficits before the treatment. Biological equivalent dose (BED) with alpha/beta ratios of 10 ranged from 39 to 50.7 Gy (median 44.8 Gy).Results: The median observation period was 5.1 months ranging from 0.9 to 36.0 months. Among the 24 patients, five(21%) underwent salvage therapies, while of the remaining 19 patients four (21%) became nonambulatory by the last follow-up. The ambulatory rates at 3 months and 6 months were 85 and 63%, respectively. The local progression-free rates at 3 months and 6 months were 53 and 47%, respectively.Conclusions: Radiotherapy with a BED of 39-50.7 Gy (median 44.8 Gy) is not sufficiently effective for the patients with spinal bone metastases from HCC to prevent paralysis. Dose escalation with a highly precise radiation technique will need to be evaluated.